8-11853379-G-T

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2

The NM_001908.5(CTSB):​c.76C>A​(p.Leu26Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,611,966 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L26P) has been classified as Benign.

Frequency

Genomes: 𝑓 0.000066 ( 0 hom., cov: 27)
Exomes 𝑓: 0.000017 ( 0 hom. )

Consequence

CTSB
NM_001908.5 missense

Scores

1
8
9

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.54

Publications

64 publications found
Variant links:
Genes affected
CTSB (HGNC:2527): (cathepsin B) This gene encodes a member of the C1 family of peptidases. Alternative splicing of this gene results in multiple transcript variants. At least one of these variants encodes a preproprotein that is proteolytically processed to generate multiple protein products. These products include the cathepsin B light and heavy chains, which can dimerize to form the double chain form of the enzyme. This enzyme is a lysosomal cysteine protease with both endopeptidase and exopeptidase activity that may play a role in protein turnover. It is also known as amyloid precursor protein secretase and is involved in the proteolytic processing of amyloid precursor protein (APP). Incomplete proteolytic processing of APP has been suggested to be a causative factor in Alzheimer's disease, the most common cause of dementia. Overexpression of the encoded protein has been associated with esophageal adenocarcinoma and other tumors. Both Cathepsin B and Cathepsin L are involved in the cleavage of the spike protein from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) upon its entry to the human host cell. Multiple pseudogenes of this gene have been identified. [provided by RefSeq, Sep 2020]
CTSB Gene-Disease associations (from GenCC):
  • keratolytic winter erythema
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BS2
High AC in GnomAd4 at 10 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001908.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CTSB
NM_001908.5
MANE Select
c.76C>Ap.Leu26Met
missense
Exon 2 of 10NP_001899.1
CTSB
NM_001317237.2
c.-178C>A
5_prime_UTR_premature_start_codon_gain
Exon 3 of 10NP_001304166.1
CTSB
NM_001384714.1
c.76C>Ap.Leu26Met
missense
Exon 2 of 10NP_001371643.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CTSB
ENST00000353047.11
TSL:1 MANE Select
c.76C>Ap.Leu26Met
missense
Exon 2 of 10ENSP00000345672.5
CTSB
ENST00000533455.6
TSL:1
c.76C>Ap.Leu26Met
missense
Exon 4 of 12ENSP00000432244.1
CTSB
ENST00000531551.5
TSL:1
n.76C>A
non_coding_transcript_exon
Exon 3 of 10ENSP00000436456.1

Frequencies

GnomAD3 genomes
AF:
0.0000665
AC:
10
AN:
150460
Hom.:
0
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000599
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000488
GnomAD2 exomes
AF:
0.0000239
AC:
6
AN:
251104
AF XY:
0.0000221
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000171
AC:
25
AN:
1461388
Hom.:
0
Cov.:
44
AF XY:
0.0000206
AC XY:
15
AN XY:
726988
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33464
American (AMR)
AF:
0.000179
AC:
8
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.000302
AC:
12
AN:
39692
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86240
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53358
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
9.00e-7
AC:
1
AN:
1111666
Other (OTH)
AF:
0.0000331
AC:
2
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000664
AC:
10
AN:
150578
Hom.:
0
Cov.:
27
AF XY:
0.0000681
AC XY:
5
AN XY:
73404
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
40896
American (AMR)
AF:
0.000598
AC:
9
AN:
15044
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3462
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5068
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4718
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10364
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67750
Other (OTH)
AF:
0.000483
AC:
1
AN:
2072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
6740
ExAC
AF:
0.0000247
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Jun 28, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is present in population databases (rs12338, gnomAD 0.01%). This sequence change replaces leucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 26 of the CTSB protein (p.Leu26Met). This variant has not been reported in the literature in individuals affected with CTSB-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The methionine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.081
T
BayesDel_noAF
Benign
-0.13
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.24
T
Eigen
Uncertain
0.21
Eigen_PC
Benign
0.044
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.71
T
M_CAP
Benign
0.060
D
MetaRNN
Uncertain
0.62
D
MetaSVM
Uncertain
-0.066
T
MutationAssessor
Pathogenic
3.5
M
PhyloP100
1.5
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-1.4
N
REVEL
Uncertain
0.41
Sift
Uncertain
0.011
D
Sift4G
Uncertain
0.018
D
Polyphen
0.97
D
Vest4
0.42
MutPred
0.75
Gain of disorder (P = 0.0961)
MVP
0.54
ClinPred
0.63
D
GERP RS
2.4
PromoterAI
0.038
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.53
gMVP
0.68
Mutation Taster
=76/24
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12338; hg19: chr8-11710888; API